Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Martina Giannotta"'
Autor:
Riccardo Morganti, Ivano Biviano, Siro Bagnoli, Francesca Calella, Sara Naldini, E.N. Lynch, Lorenzo Bertani, Linda Ceccarelli, Paolo Lionetti, Simona Maltinti, Alberto Pieraccini, G. Tapete, Moira Minciotti, Francesca De Nigris, Martina Giannotta, Francesco Costa, Maria Gloria Mumolo, Monica Milla, Silvia Rentini
Publikováno v:
Inflammatory Bowel Diseases. 28:62-69
Background Few data are currently available about SB5 in inflammatory bowel diseases (IBD). The aim of this study was to assess the effectiveness and safety of SB5 in a cohort of patients with IBD in stable remission switched from the adalimumab (ADA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b74f862fee62621fb769e9647058a99
https://doi.org/10.1093/ibd/izab027
https://doi.org/10.1093/ibd/izab027
Autor:
Stefano Scaringi, Natalia Manetti, Martina Giannotta, Saverio Caini, Vito Annese, Simona Deiana, Siro Bagnoli
Publikováno v:
Digestive and Liver Disease. 48:1432-1437
Background and aim We aimed to evaluate the outcome of patients with acute severe ulcerative colitis previously exposed to immunosuppressive (IMS) therapy. Methods We retrospectively collected data from 86 consecutive patients from 2008. Early outcom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7300b85ec109024b9be853b5a0fc9464
https://doi.org/10.1016/j.dld.2016.07.021
https://doi.org/10.1016/j.dld.2016.07.021
Autor:
Natalia Manetti, Siro Bagnoli, Andrea Bonanomi, Francesca Rogai, Giancarlo Vannozzi, Martina Giannotta, Vito Annese
Publikováno v:
Inflammatory Bowel Diseases. 22:1945-1953
BACKGROUND The disease course and colectomy rate of ulcerative colitis (UC) vary largely in population-based and referral center cohorts. We retrospectively evaluated our cohort to determine the disease course and risk factors for colectomy. METHODS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d4d327fde97d365370d2f9a408c4b4f
https://doi.org/10.1097/mib.0000000000000787
https://doi.org/10.1097/mib.0000000000000787
Autor:
Stefano Milani, Monica Milla, Veronica Almerigogna, Andrea Cozzi, Martina Giannotta, G. Tapete, Silvia Biagini
Publikováno v:
International Journal of Digestive Diseases. 2
Background: Increasing evidences suggest that hypovitaminosis D can play an important role in immuno-mediated diseases, such as Inflammatory Bowel Diseases (IBD). The hypovitaminosis D is an established risk factor for the development of osteopenia,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4ba25edd8a348ae7e3831335e0f77527
https://doi.org/10.4172/2472-1891.100013
https://doi.org/10.4172/2472-1891.100013
Publikováno v:
Thrombosis Journal
Inflammatory bowel disease affects more than 2 million people in Europe, with almost 20% of patients being diagnosed in pediatric age. Patients with inflammatory bowel disease are at increased risk of thromboembolic complications which may affect pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba05a6f1b42727a4871bf05c4bc7d759
https://pubmed.ncbi.nlm.nih.gov/25866483
https://pubmed.ncbi.nlm.nih.gov/25866483
Autor:
Vieri, Vannucchi, Maddalena, Grazzini, Filippo, Pieralli, Martina, Giannotta, Cristina, Biagioni, Carlo, Nozzoli
Publikováno v:
Journal of gastrointestinal and liver diseases : JGLD. 20(2)
The anti-tumor necrosis factor (TNF) agents are drugs that in recent years turned out to be a mainstay of therapy for the treatment of inflammatory bowel disease. Nevertheless, they have several adverse effects such as infectious complications and im
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::334bd9a87bb26fcd88d14b4e9955a2f4
https://pubmed.ncbi.nlm.nih.gov/21725519
https://pubmed.ncbi.nlm.nih.gov/21725519
Autor:
S. Genise, Monica Milla, Francesca Rogai, Alessia Settesoldi, Vito Annese, Natalia Manetti, Siro Bagnoli, Cristina Cenci, Martina Giannotta, Manuela Coppola, Andrea Bonanomi, Giancarlo Vannozzi
Publikováno v:
Gastroenterology. 144:S-628
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2df6a72dde563be9e2ce7104070d0613
https://doi.org/10.1016/s0016-5085(13)62328-8
https://doi.org/10.1016/s0016-5085(13)62328-8